In the turbulent seas of the global synthetic biology industry, Zymergen, an American biotechnology company based in Emeryville, California, has been steadfastly navigating its way through the storm. The firm’s journey has not been without its share of significant challenges and strategic pivots, punctuated by the bankruptcy declaration of their major competitor, Amyris, two years […]